Assertio Holdings, Inc. (ASRT)
Jun 16, 2026 - ASRT was delisted (reason: merged with Zydus Lifesciences)
23.50
+0.02 (0.09%)
Inactive · Last trade price on Jun 15, 2026
Assertio Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 101.56 | 118.71 | 122.86 | 151.88 | 157.52 | 112 |
Other Revenue | 0.6 | - | 2.1 | 0.19 | -1.29 | -0.99 |
| 102.16 | 118.71 | 124.96 | 152.07 | 156.23 | 111.01 | |
Revenue Growth | -14.15% | -5.00% | -17.83% | -2.67% | 40.73% | 2.72% |
Cost of Revenue | 30.31 | 35.38 | 39.23 | 27.02 | 18.75 | 15.23 |
Gross Profit | 71.85 | 83.33 | 85.73 | 125.05 | 137.49 | 95.78 |
Selling, General & Admin | 66.46 | 69 | 75.05 | 69.74 | 48.1 | 46.48 |
Research & Development | 1.71 | 1.69 | 3.82 | 2.84 | - | - |
Amortization of Goodwill & Intangibles | 26.43 | 29.86 | 25.64 | 27.53 | 32.61 | 28.11 |
Operating Expenses | 94.6 | 100.55 | 104.52 | 100.11 | 80.71 | 74.6 |
Operating Income | -22.75 | -17.22 | -18.78 | 24.94 | 56.77 | 21.18 |
Interest Expense | -3.09 | -3.08 | -3.04 | -3.38 | -7.96 | -10.22 |
Interest & Investment Income | 2.41 | 2.67 | 3.22 | 2.4 | - | - |
Other Non Operating Income (Expenses) | 0.16 | 0.18 | 2.77 | -9.54 | -0.96 | -0.31 |
EBT Excluding Unusual Items | -23.26 | -17.45 | -15.84 | 14.42 | 47.85 | 10.65 |
Merger & Restructuring Charges | -2.6 | -2.89 | -0.72 | -14.38 | - | -1.69 |
Gain (Loss) on Sale of Assets | -8.17 | -8.17 | - | - | - | - |
Asset Writedown | -1.7 | -1.7 | -5.22 | -279.64 | - | - |
Legal Settlements | - | - | - | - | - | -10.6 |
Other Unusual Items | 0.28 | 0.28 | 0.24 | 25.54 | -18.69 | -3.91 |
Pretax Income | -35.46 | -29.94 | -21.53 | -254.05 | 31.17 | -0.55 |
Income Tax Expense | 0.24 | 0.44 | 0.05 | 77.89 | -78.46 | 0.73 |
Net Income | -35.69 | -30.38 | -21.58 | -331.94 | 109.63 | -1.28 |
Net Income to Common | -35.69 | -30.38 | -21.58 | -331.94 | 109.63 | -1.28 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 6 | 6 | 6 | 5 | 3 | 3 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 5 | 4 | 3 |
Shares Change | 0.86% | 0.82% | 34.12% | 29.93% | 26.64% | 64.71% |
EPS (Basic) | -5.56 | -4.74 | -3.40 | -70.10 | 34.98 | -0.45 |
EPS (Diluted) | -5.56 | -4.74 | -3.40 | -70.10 | 30.51 | -0.45 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -7.08 | -28.18 | 26.41 | 48.98 | 78.32 | 5.47 |
Free Cash Flow Per Share | -1.10 | -4.40 | 4.16 | 10.34 | 21.49 | 1.90 |
Gross Margin | 70.33% | 70.19% | 68.61% | 82.23% | 88.00% | 86.28% |
Operating Margin | -22.27% | -14.51% | -15.03% | 16.40% | 36.34% | 19.08% |
Profit Margin | -34.94% | -25.59% | -17.27% | -218.28% | 70.17% | -1.15% |
Free Cash Flow Margin | -6.93% | -23.74% | 21.13% | 32.21% | 50.13% | 4.93% |
EBITDA | 3.83 | 12.78 | 7.05 | 53.17 | 90.17 | 50.26 |
EBITDA Margin | 3.75% | 10.77% | 5.64% | 34.96% | 57.72% | 45.27% |
D&A For EBITDA | 26.58 | 30.01 | 25.83 | 28.23 | 33.4 | 29.08 |
EBIT | -22.75 | -17.22 | -18.78 | 24.94 | 56.77 | 21.18 |
EBIT Margin | -22.27% | -14.51% | -15.03% | 16.40% | 36.34% | 19.08% |
Revenue as Reported | 102.16 | 118.71 | 124.96 | 152.07 | 156.23 | 111.01 |
Advertising Expenses | - | 1.3 | 1.8 | 4.4 | 3.4 | 1.8 |